Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marrone Bio Innovations Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
Financial Survey: Marrone Bio Innovations (MBII) vs. Ciner Resources (CINR)
Marrone Bio Innovations (NASDAQ: MBII) and Ciner Resources (NYSE:CINR) are both small-cap basic materials companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitabiliy, dividends, risk, analyst recommendations, earnings and institutional ownership.
Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marrone Bio Innovations Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
Institutional and Insider Ownership
29.5% of Marrone Bio Innovations shares are held by institutional investors. Comparatively, 9.0% of Ciner Resources shares are held by institutional investors. 7.3% of Marrone Bio Innovations shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Profitability
This table compares Marrone Bio Innovations and Ciner Resources’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Marrone Bio Innovations | -189.32% | N/A | -59.64% |
| Ciner Resources | 8.68% | 16.31% | 10.20% |
Dividends
Ciner Resources pays an annual dividend of $2.27 per share and has a dividend yield of 8.3%. Marrone Bio Innovations does not pay a dividend. Ciner Resources pays out 108.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.
Analyst Recommendations
This is a summary of recent recommendations and price targets for Marrone Bio Innovations and Ciner Resources, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Marrone Bio Innovations | 0 | 2 | 1 | 0 | 2.33 |
| Ciner Resources | 0 | 2 | 1 | 0 | 2.33 |
Marrone Bio Innovations currently has a consensus target price of $1.75, indicating a potential upside of 49.57%. Ciner Resources has a consensus target price of $32.17, indicating a potential upside of 17.23%. Given Marrone Bio Innovations’ higher probable upside, analysts plainly believe Marrone Bio Innovations is more favorable than Ciner Resources.
Volatility and Risk
Marrone Bio Innovations has a beta of 0.31, meaning that its stock price is 69% less volatile than the S&P 500. Comparatively, Ciner Resources has a beta of 0.97, meaning that its stock price is 3% less volatile than the S&P 500.
Valuation and Earnings
This table compares Marrone Bio Innovations and Ciner Resources’ top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | EBITDA | Earnings Per Share | Price/Earnings Ratio | |
| Marrone Bio Innovations | $15.53 million | 2.36 | -$19.96 million | N/A | N/A |
| Ciner Resources | $487.40 million | 1.13 | $118.90 million | $2.10 | 13.07 |
Ciner Resources has higher revenue and earnings than Marrone Bio Innovations.
Summary
Ciner Resources beats Marrone Bio Innovations on 7 of the 12 factors compared between the two stocks.
Marrone Bio Innovations Company Profile
Ciner Resources Company Profile